Drug Trial Radar · NCT05667493
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Last checked: Nov 20, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
1,400
Planned (sponsor's estimate)
Start
Nov 30, 2022
Primary completion
Aug 2029
Study completion Aug 2029
Sponsor
- Lead sponsor
- Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
- Sponsor type
- Industry
- Collaborators
- AstraZeneca
- First posted
- Dec 28, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and tolerability of extended dosing with eplontersen in participants with ATTR-CM.
Conditions
- Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
Interventions
EplontersenDrug
Eplontersen will be administered by SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse Events (AE) and Serious Adverse Events (SAE)Time frame: Baseline up to 36 months
- Change From Baseline in Platelet CountTime frame: Baseline up to 36 months
- Change From Baseline in Estimated Glomerular Filtration Rate (eGFR)Time frame: Baseline up to 36 months
- Change From Baseline in Urine Protein Creatinine Ratio (UPCR)Time frame: Baseline up to 36 months
Locations
134 sites in 20 countries. Site status is shown where the registry gives one.
Mayo Clinic
Scottsdale, Arizona
Cedars-Sinai Medical Center
Beverly Hills, California
Altman Clinical and Translational Research Institute - Center for Clinical Research
La Jolla, California
University Of California San Francisco Urology Practice
San Francisco, California
Stanford University (Leland Stanford Junior University)
Stanford, California
University of Colorado Hospital - Anschutz Medical Campus
Aurora, Colorado
MedStar Washington Hospital Center
Washington D.C., District of Columbia
The George Washington Medical Faculty Associates - Foggy Bottom North Pavilion
Washington D.C., District of Columbia
Cleveland Clinic Florida
Weston, Florida
Piedmont Heart of Fayetteville
Atlanta, Georgia
Emory Heart and Vascular Center - Emory Clifton Campus
Atlanta, Georgia
Piedmont Atlanta Hospital
Fayetteville, Georgia
Northwestern University
Chicago, Illinois
Loyola University Medical Center
Maywood, Illinois
Indiana University Health University Hospital
Indianapolis, Indiana
University of Kansas Medical Center (KUMC)
Kansas City, Kansas
University of Kansas Medical Center
Kansas City, Kansas
University of Maryland Medical Center
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts
Boston University School of Medicine
Boston, Massachusetts
Henry Ford Health System
Detroit, Michigan
Allina Health Minneapolis Heart Institute - Abbott Northwestern's Heart Hospital
Minneapolis, Minnesota
Mayo Clinic
Rochester, Minnesota
Saint Luke's Hospital of Kansas City
Kansas City, Missouri
Barnes-Jewish Hospital
St Louis, Missouri
New York University Langone Cardiology Associates
New York, New York
Weill Cornell Medicine Cardiology
New York, New York
Columbia University Irving Medical Center
New York, New York
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Duke University Medical Center
Durham, North Carolina
Carl and Edyth Lindner Research Center at The Christ Hospital
Cincinnati, Ohio
University Hospitals Cleveland Medical Center
Cleveland, Ohio
Cleveland Clinic Main Campus
Cleveland, Ohio
The Ohio State University College of Medicine
Columbus, Ohio
Oregon Health and Science University
Portland, Oregon
Lancaster General Hospital
Lancaster, Pennsylvania
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
Medical University of South Carolina
Charleston, South Carolina
Vanderbilt Heart and Vascular Institute
Nashville, Tennessee
Showing 40 of 134 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.